CD274 and neoplasm: However, CheckMate-141 (6) failed to demonstrate a significant association between PD-L1 expression, using different thresholds of expression in tumor cells, response rates to the anti-PD-1 nivolumab and OS not allowing any selection of patients eligible for treatment.